SPRY2 and hepatocellular carcinoma: miR-330-5p overexpression promotes HCC proliferation and growth through targeting Sprouty2 (SPRY2) mediated mitogen-activated protein kinase (MAPK)/extracellular regulated kinase (ERK) signaling.